Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001534899-12-000001
Filing Date
2012-01-06
Accepted
2012-01-06 16:01:26
Documents
1
Effectiveness Date
2012-01-06
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9290
  Complete submission text file 0001534899-12-000001.txt   10316
Mailing Address 128 SPRING ST., STE 620 LEXINGTON MA 02421
Business Address 128 SPRING ST., STE 620 LEXINGTON MA 02421 781-861-0062
AVAXIA BIOLOGICS, Inc (Filer) CIK: 0001534899 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-168953 | Film No.: 12514579